These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22388003)

  • 21. [Research of oral prodrugs: opportunities and challenges].
    Cao F; Ping QN; Chen J
    Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering strategies to enhance nanoparticle-mediated oral delivery.
    Yamanaka YJ; Leong KW
    J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the gastrointestinal absorption and bioavailability of fenofibrate and fenofibric acid in humans.
    Zhu T; Ansquer JC; Kelly MT; Sleep DJ; Pradhan RS
    J Clin Pharmacol; 2010 Aug; 50(8):914-21. PubMed ID: 20145261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral drug delivery utilizing intestinal OATP transporters.
    Tamai I
    Adv Drug Deliv Rev; 2012 May; 64(6):508-14. PubMed ID: 21824501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study.
    Rao SV; Yajurvedi K; Shao J
    Int J Pharm; 2008 Oct; 362(1-2):16-9. PubMed ID: 18650037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
    Maher S; Leonard TW; Jacobsen J; Brayden DJ
    Adv Drug Deliv Rev; 2009 Dec; 61(15):1427-49. PubMed ID: 19800376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs.
    Kang BK; Lee JS; Chon SK; Jeong SY; Yuk SH; Khang G; Lee HB; Cho SH
    Int J Pharm; 2004 Apr; 274(1-2):65-73. PubMed ID: 15072783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery.
    Varma MV; Perumal OP; Panchagnula R
    Curr Opin Chem Biol; 2006 Aug; 10(4):367-73. PubMed ID: 16814593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional matrices for oral peptide delivery.
    Bernkop-Schnürch A; Walker G
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
    Wu H; Zhou A; Lu C; Wang L
    Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats.
    Sun M; Zhai X; Xue K; Hu L; Yang X; Li G; Si L
    Eur J Pharm Sci; 2011 Jun; 43(3):132-40. PubMed ID: 21530655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lessons learned from marketed and investigational prodrugs.
    Ettmayer P; Amidon GL; Clement B; Testa B
    J Med Chem; 2004 May; 47(10):2393-404. PubMed ID: 15115379
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.
    Chen Y; Lu Y; Chen J; Lai J; Sun J; Hu F; Wu W
    Int J Pharm; 2009 Jul; 376(1-2):153-60. PubMed ID: 19394416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of intestinal permeability: an innovative method of oral drug delivery for the treatment of inherited and acquired human diseases.
    Fasano A
    Mol Genet Metab; 1998 May; 64(1):12-8. PubMed ID: 9682213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development.
    Majumdar S; Duvvuri S; Mitra AK
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1437-52. PubMed ID: 15191791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.
    Müllertz A; Ogbonna A; Ren S; Rades T
    J Pharm Pharmacol; 2010 Nov; 62(11):1622-36. PubMed ID: 21039546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Optimization of intestinal drug absorption by drug delivery system (DDS) technology].
    Ogawara K
    Nihon Yakurigaku Zasshi; 2009 May; 133(5):266-9. PubMed ID: 19443963
    [No Abstract]   [Full Text] [Related]  

  • 39. The survey of the use of QSAR methods to determine intestinal absorption and oral bioavailability during drug design.
    Silva FT; Trossini GH
    Med Chem; 2014; 10(5):441-8. PubMed ID: 24730584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clearing away barriers to oral drug delivery.
    Xia D; Wood-Yang AJ; Prausnitz MR
    Sci Robot; 2022 Sep; 7(70):eade3311. PubMed ID: 36170379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.